Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
TB-500 vs BPC-157: A Side-by-Side Research Comparison TB-500 (Thymosin Beta-4) and BPC-157 are frequently studied together for tissue repair applications
The abuse of alcohol causes steatosis/liver injury as well as malnutrition leading to deficiencies in vitamin (B1, B2, B6, B12, C, K, A, and D) and minerals (selenium, zinc, magnesium, iron, and phosphorus) that significantly affect cellular metabolism as well as the epigenetic profile
Immunovant Sector: Pharmaceuticals and biotechnology (autoimmune and immunology therapeutics) HQ: 320 W 37th St., New York, NY Year Founded: 2018 Key Leaders: Eric Venker, MD, PharmD, CEO Number of Employees: 362 Stage: Public Financial Snapshot: $3.83 billion Notable Investors: SG Americas Securities, Roivant Sciences, RTW Investments, and BVF Partners Key Products: Immunovant is developing Batoclimab, an FcRn-targeting monoclonal antibody for autoimmune diseases (MG, TED, Graves disease), which is in Phase 3 registrational trials
Pomegranate peel extract prevents liver fibrosis in biliary-obstructed rats
US$ 24.62
US$ 21.00
US$ 25.96
US$ 22.74
